Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Xu, Zhizhong ^a   Shen, Guobo ^a   Xia, Xiangying ^a   Zhao, Xinyu ^a   Zhang, Peng ^a   Wu, Huanhuan ^b   Guo, Qingfa ^a   Qian, Zhiyong ^a   Wei, Yuquan ^a   Liang, Shufang ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Gene delivery; Polyethyleneimine nanoparticle; Renal cell carcinoma; VHL

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BIOMATERIAL; FOLIC ACID POLY(EPSILON CAPROLACTONE) ISOPHORONE DIIDOCYANATE POLYETHYLENEIMINE; GREEN FLUORESCENT PROTEIN; HEPARIN POLYETHYLENEIMINE; NANOPARTICLE; POLY(EPSILON CAPROLACTONE) PLURONIC POLY(EPSILON CAPROLACTONE) GRAFTED POLYETHYENEIMINE; POLYETHYLENEIMINE DERIVATIVE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO GENE TRANSFER; KIDNEY CARCINOMA; MARKER GENE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUDE MOUSE; PARTICLE SIZE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY TESTING; TUMOR VOLUME; ZETA POTENTIAL; GENE THERAPY; KIDNEY TUMOR; TUMOR CELL LINE;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; GENE THERAPY; HUMANS; KIDNEY NEOPLASMS; NANOPARTICLES;

EID: 79955019832     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-46     Document Type: Article

References (32)

1. Xu K, Ding Q, Fang Z, Zheng J, Gao P, Lu Y, Zhang Y. Silencing of HIF-1α suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis. Cancer Gene Ther 2010, 17:212-222. 10.1038/cgt.2009.66, 19816521.
2. Morikawa T, Sugiyama A, Kume H, Ota S, Kashima T, Tomita K, Kitamura T, Kodama T, Fukayama M, Aburatani H. Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin Cancer Res 2007, 13:5703-5709. 10.1158/1078-0432.CCR-07-0603, 17908959.
3. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003, 27:612-624. 10.1097/00000478-200305000-00005, 12717246.
4. Shi S, Guo Q, Kan B, Fu S, Wang X, Gong C, Deng H, Luo F, Zhao X, Wei Y, Qian Z. A novel Poly(ε-caprolactone)-Pluronic-Poly(ε-caprolactone) grafted Polyethyleneimine(PCFC-g-PEI), Part 1, synthesis,cytotoxicity, and in vitro transfection study. BMC Biotechnol 2009, 9:65-77. 10.1186/1472-6750-9-65, 2717081, 19607728.
5. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. Progress in developingcationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29:3477-3496. 10.1016/j.biomaterials.2008.04.036, 18499247.
6. Kreiss P, Cameron B, Rangara R, Mailhe P, Aguerre-Charriol O, Airiau M, Scherman D, Crouzet J, Pitard B. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res 1999, 27:3792-3798. 10.1093/nar/27.19.3792, 148641, 10481017.
7. Corsi K, Chellat F, Yahia L, Fernandes JC. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003, 24:1255-1264. 10.1016/S0142-9612(02)00507-0, 12527266.
8. Toncheva V, Wolfert MA, Dash PR, Oupicky D, Ulbrich K, Seymour LW, Schacht EH. Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. Biochim Biophys Acta 1998, 1380:354-368.
9. Aoki1 K, Furuhata S, Hatanaka K, Maeda M, Remy JS, Behr JP, Terada M, Yoshida T. Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Ther 2001, 8:508-514. 10.1038/sj.gt.3301435, 11319617.
10. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995, 92:7297-7301. 10.1073/pnas.92.16.7297, 41326, 7638184.
11. Godbey WT, Wu KK, Mikos AG. Poly (ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials 2000, 22:471-480.
12. Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 1999, 45:268-275. 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q, 10397985.
13. Fischer D, Bieber T, Li Y, Elsässer HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weigh on transfection efficiency and cytotoxicity. Pharm Res 1999, 16:1273-1279. 10.1023/A:1014861900478, 10468031.
14. Furgeson DY, Chan WS, Yockman JW, Kim SW. Modified linear polyethylenimine-cholesterol conjugates for DNA complexation. Bioconjugate Chem 2003, 14:840-847.
15. Furgeson DY, Yockman JW, Janat MM, Kim SW. Tumor efficacy and biodistribution of linear polyethylenimine-cholesterol/DNA complexes. Mol Therapy 2004, 9:837-845.
16. Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliver Rev 2002, 54:675-693.
17. Zhao J, Gou M, Dai M, Li X, Cao M, Huang M, Wen Y, Kan B, Qian Z, Wei Y. Preparation, characterization, and in vitro cytotoxicity study of cationic PCL-pluronic-PCL (PCFC) nanoparticles for gene delivery. J Biomed Mater Res 2009, 90:506-513.
18. Gou M, Men K, Zhang J, Li Y, Song J, Luo S, Shi H, Wen Y, Guo G, Huang M, Zhao X, Qian Z, Wei Y. Efficiently inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethylenimine. ACS Nano 2010, 4:5573-5584. 10.1021/nn1005599, 20839784.
19. Liu T, Yu X, Kan B, Guo Q, Wang X, Shi S, Guo G, Luo F, Zhao X, Wei Y, Qian Z. Enhanced gene delivery using IPDI crosslinked low molecular weight polyethylenimine with PCFC conjugate. J Biomed Nanotechnol 2010, 6:1-9. 10.1166/jbn.2010.1098, 20499827.
20. Jones C, Grainger DW. In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev 2009, 61:438-456. 10.1016/j.addr.2009.03.005, 2763955, 19383522.
21. Wen Y, Wang C, Ma T, Li Z, Zhou L, Mu B, Leng F, Shi H, Li Y, Wei Y. Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model. Cancer Sci 2010, 101:2325-2332. 10.1111/j.1349-7006.2010.01695.x, 20804499.
22. Liang S, Xu Y, Shen G, Zhao X, Zhou J, Li X, Gong F, Ling B, Fang L, Huang C, Wei Y. Gene expression and methylation status of 14-3-3σ in human renal carcinoma tissues. IUBMB Life 2008, 60:534-540. 10.1002/iub.75, 18548556.
23. Liang S, Fu A, Zhang Q, Tang M, Zhou J, Wei Y, Chen L. Honokiol inhibits cell migration via IQGAP1 downregulation discovered by a quantitative pharmaceutical proteomic analysis. Proteomics 2010, 10:1474-1483. 10.1002/pmic.200900649, 20127691.
24. Thomas M, Lu J, Ge Q, Zhang C, Chen J, Klibanov AM. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci USA 2005, 102:5679-5684. 10.1073/pnas.0502067102, 556302, 15824322.
25. Jeon O, Yang HS, Lee TJ, Kim BS. Heparin-conjugated polyethylenimine for gene delivery. J Control Release 2008, 132:236-242. 10.1016/j.jconrel.2008.05.017, 18597881.
26. Guillem VM, Aliño SF. Transfection pathways of nonspecific and targeted PEI-polyplexes. Gene Ther Mol Biol 2004, 8:369-384.
27. Astafieva I, Maksimova I, Lukanidin E, Alakhov V, Kabanov A. Enhancement of the polycation-mediated DNA uptake and cell transfection with Pluronic P85 block copolymer. FEBS Lett 1996, 389:278-280. 10.1016/0014-5793(96)00607-2, 8766715.
28. Arote R, Kim TH, Kim YK, Hwang SK, Jiang HL, Song HH, Nah JW, Cho MH, Cho CS. A biodegradable poly(esteramine ) based on polycaprolactone and polyethylenimine as a gene carrier. Biomaterials 2007, 28:735-744. 10.1016/j.biomaterials.2006.09.028, 17034844.
29. Andrew RH, Philip SL. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 2005, 94:2135-2146. 10.1002/jps.20457, 16136558.
30. Masakazu O, Toru S, Junlin Y, Liu JY, Qu RJ, Harada H, Hiraoka M. A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas. Cancer Sci 2005, 5:288-294.
31. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000, 41:147-162. 10.1016/S0169-409X(99)00062-9, 10699311.
32. Lee RJ, Wang S, Low PS. Measurement of endosome pH following folate receptor-mediated endocytosis. Biochim Biophys Acta 1996, 1312:237-242. 10.1016/0167-4889(96)00041-9, 8703993.